Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance حسب Peng He (24579)

الموضوعات:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance حسب Peng He (24579)

الموضوعات:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance حسب Peng He (24579)

الموضوعات:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance حسب Peng He (24579)

الموضوعات:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance حسب Peng He (24579)

الموضوعات:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance حسب Peng He (24579)

الموضوعات:

Additional file 3 of COX-2 inhibition as a therapeutic strategy for bone loss in Staphylococcus aureus osteomyelitis حسب Yuhui Chen (150020)

الموضوعات:

Additional file 1 of COX-2 inhibition as a therapeutic strategy for bone loss in Staphylococcus aureus osteomyelitis حسب Yuhui Chen (150020)

الموضوعات:

Additional file 2 of COX-2 inhibition as a therapeutic strategy for bone loss in Staphylococcus aureus osteomyelitis حسب Yuhui Chen (150020)

الموضوعات:

PGRN deletion decreased the susceptibility to invasive <i>C</i>.<i>albicans</i> infection in mice. حسب Jiayu Liu (3951515)

CCR Translation for This Article from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8⁺ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic S... حسب Marieke F. Fransen (3699181)

<i>CHGA</i> mRNA expression decreases with <i>CYB561</i> knockdown. حسب Romie Angelo G. Azur (18547651)

Supplementary Table 3 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Table 1 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Table 2 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Figure 3 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Figure 2 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Figure 4 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Figure 1 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Lung tumor development decreases the proportions of CD103⁺XCR1⁺ DC1s. حسب Julyanne Brassard (4117441)